{"transactions":[{"id":1118363,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T20:07:47.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":6510,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs that will vest in equal installments as follows: on grant, July 1, 2025, October 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":134531,"source":{"system":"sec-edgar","filing":"0001213900-25-052620","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025052620/ownership.xml","form_type":"4"}},{"id":1118362,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T20:07:47.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in equal portions of 10,000 as follows: January 1, 2026, January 1, 2027 and January 1, 2028. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":128021,"source":{"system":"sec-edgar","filing":"0001213900-25-052620","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025052620/ownership.xml","form_type":"4"}},{"id":1684519,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-08T21:37:19.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":9325,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in quarterly installments of approximately 2,331 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":98021,"source":{"system":"sec-edgar","filing":"0001209191-24-001143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919124001143/doc4.xml","form_type":"4"}},{"id":1684518,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-08T21:37:19.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":88696,"source":{"system":"sec-edgar","filing":"0001209191-24-001143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919124001143/doc4.xml","form_type":"4"}},{"id":1916602,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-20T10:00:31.000Z","date":"2023-04-17","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in equal quarterly installments of 2,500 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":58696,"source":{"system":"sec-edgar","filing":"0001209191-23-024942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919123024942/doc4.xml","form_type":"4"}},{"id":2189824,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-08-10T20:30:51.000Z","date":"2022-08-08","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested as follows: 10,000 vested on each of January 1, 2013 and 2014."}],"balance_after":0,"derivative":{"exercise_price":4.08,"expiration_date":"2022-08-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-045207","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919122045207/doc4.xml","form_type":"4"}},{"id":2189823,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-10T20:30:51.000Z","date":"2022-08-08","kind":"tax_withholding","acquired":false,"shares":9304,"price":8.77,"value":81596.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a cashless exercise of outstanding stock options to purchase 20,000 shares of common stock. The reporting person received 10,696 shares of common stock and surrendered 9,304 shares of common stock underlying the stock option in payment of the exercise price."}],"balance_after":28696,"source":{"system":"sec-edgar","filing":"0001209191-22-045207","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919122045207/doc4.xml","form_type":"4"}},{"id":2189822,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-10T20:30:51.000Z","date":"2022-08-08","kind":"exercise","acquired":true,"shares":20000,"price":4.08,"value":81600.0,"ownership":{"direct":true},"balance_after":38000,"source":{"system":"sec-edgar","filing":"0001209191-22-045207","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919122045207/doc4.xml","form_type":"4"}},{"id":2199211,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T00:00:42.000Z","date":"2022-07-28","kind":"grant","acquired":true,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in 3 installments as follows: 4,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person previously reported and disclaimed beneficial ownership over 138,889 shares of common stock owned by a company wholly owned by a trust of which the reporting person was previously a trustee. The reporting person resigned as a trustee of such trust, effective February 3, 2022."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001209191-22-043766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919122043766/doc4.xml","form_type":"4"}},{"id":2444643,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T01:52:53.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026."}],"balance_after":10000,"derivative":{"exercise_price":13.89,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-22-000822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022000822/ownership.xml","form_type":"4"}},{"id":2444642,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T01:52:53.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001213900-22-000822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022000822/ownership.xml","form_type":"4"}},{"id":2821037,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-02T21:12:25.000Z","date":"2021-02-26","kind":"other","acquired":false,"shares":78125,"price":3.68,"value":287500.0,"ownership":{"direct":false,"nature":"Via trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported securities were transferred to the Ledo Investment Holdings Limited trust (the \"Trust\"), which is administered by an independent trustee for the benefit of the reporting person and his immediate family members. The reporting person disclaims beneficial ownership of the securities held by the Trust except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities were transferred to the Ledo Investment Holdings Limited trust (the \"Trust\"), which is administered by an independent trustee for the benefit of the reporting person and his immediate family members. The reporting person disclaims beneficial ownership of the securities held by the Trust except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-21-012894","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390021012894/ownership.xml","form_type":"4"}},{"id":2821036,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-02T21:12:25.000Z","date":"2021-02-26","kind":"other","acquired":false,"shares":375000,"price":3.68,"value":1380000.0,"ownership":{"direct":false,"nature":"Via trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported securities were transferred to the Ledo Investment Holdings Limited trust (the \"Trust\"), which is administered by an independent trustee for the benefit of the reporting person and his immediate family members. The reporting person disclaims beneficial ownership of the securities held by the Trust except to the extent of his pecuniary interest therein."},{"field":"shares","element":"transactionShares","label":"F2","text":"Due to an administrative rounding error following the Issuer's 1-to-12 reverse stock split, which occurred on January 10, 2013, the Form 4 filed for the reporting person on February 11, 2013 inadvertently understated the amount of shares beneficially owned by the reporting person following the transaction by 1 share, which error has been corrected on this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities were transferred to the Ledo Investment Holdings Limited trust (the \"Trust\"), which is administered by an independent trustee for the benefit of the reporting person and his immediate family members. The reporting person disclaims beneficial ownership of the securities held by the Trust except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-21-012894","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390021012894/ownership.xml","form_type":"4"}},{"id":3311786,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-14T21:08:12.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in 3 installments as follows: 6,666 shall vest on December 31, 2020, and 6,667 shall vest on each of December 31, 2021 and December 31, 2022."}],"balance_after":20000,"derivative":{"exercise_price":4.8,"expiration_date":"2030-01-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-20-000993","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390020000993/ownership.xml","form_type":"4"}},{"id":3417685,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-11T21:17:11.000Z","date":"2019-09-09","kind":"purchase","acquired":true,"shares":10000,"price":2.95,"value":29500.0,"ownership":{"direct":true},"balance_after":374999,"source":{"system":"sec-edgar","filing":"0001213900-19-017770","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390019017770/ownership.xml","form_type":"4"}},{"id":3417684,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-11T21:17:11.000Z","date":"2019-09-09","kind":"purchase","acquired":true,"shares":15000,"price":2.9,"value":43500.0,"ownership":{"direct":true},"balance_after":364999,"source":{"system":"sec-edgar","filing":"0001213900-19-017770","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390019017770/ownership.xml","form_type":"4"}},{"id":3459263,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-18T17:31:26.000Z","date":"2019-07-18","kind":"purchase","acquired":true,"shares":4497,"price":3.855,"value":17335.935,"ownership":{"direct":true},"balance_after":349999,"source":{"system":"sec-edgar","filing":"0001213900-19-013085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390019013085/ownership.xml","form_type":"4"}},{"id":3459262,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-18T17:31:26.000Z","date":"2019-07-17","kind":"purchase","acquired":true,"shares":10020,"price":3.7422,"value":37496.844,"ownership":{"direct":true},"balance_after":345502,"source":{"system":"sec-edgar","filing":"0001213900-19-013085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390019013085/ownership.xml","form_type":"4"}},{"id":3459261,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-18T17:31:26.000Z","date":"2019-07-17","kind":"purchase","acquired":true,"shares":20000,"price":3.5781,"value":71562.0,"ownership":{"direct":true},"balance_after":335482,"source":{"system":"sec-edgar","filing":"0001213900-19-013085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390019013085/ownership.xml","form_type":"4"}},{"id":3459260,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-18T17:31:26.000Z","date":"2019-07-16","kind":"purchase","acquired":true,"shares":20000,"price":3.4658,"value":69316.0,"ownership":{"direct":true},"balance_after":315482,"source":{"system":"sec-edgar","filing":"0001213900-19-013085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390019013085/ownership.xml","form_type":"4"}},{"id":3462012,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-15T23:02:58.000Z","date":"2019-07-11","kind":"purchase","acquired":true,"shares":1320,"price":3.22,"value":4250.4,"ownership":{"direct":true},"balance_after":295482,"source":{"system":"sec-edgar","filing":"0001213900-19-012780","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390019012780/ownership.xml","form_type":"4"}},{"id":4180742,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2017-10-25T20:35:37.000Z","date":"2017-10-23","kind":"exercise","acquired":false,"shares":6373,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares of common stock and warrants were granted to Mr. Sank as a finder's fee in connection with a 2012 private placement of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":6,"exercise_date":"2013-02-07","expiration_date":"2018-02-07","underlying":"Common Stock","underlying_shares":6373},"source":{"system":"sec-edgar","filing":"0001213900-17-010951","document":"f4102317sank_oramedpharm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017010951/f4102317sank_oramedpharm.xml","form_type":"4"}},{"id":4180741,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2017-10-25T20:35:37.000Z","date":"2017-10-23","kind":"exercise","acquired":false,"shares":5631,"price":1.1796,"value":6642.3276,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The number of shares underlying such warrant and the applicable exercise price reflect a one-for-twelve reverse stock split effected by the issuer on January 22, 2013."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares and warrants were purchased as \"units\" at a price per unit of $4.44 in connection with the Issuer's 2012 private placement. The consideration was allocated to the shares and warrants based on relative fair value. The value allocated to the warrants was estimated by using the Black Scholes option-pricing model."}],"balance_after":0,"derivative":{"exercise_price":6,"exercise_date":"2012-11-02","expiration_date":"2017-11-02","underlying":"Common Stock","underlying_shares":5631},"source":{"system":"sec-edgar","filing":"0001213900-17-010951","document":"f4102317sank_oramedpharm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017010951/f4102317sank_oramedpharm.xml","form_type":"4"}},{"id":4180740,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-25T20:35:37.000Z","date":"2017-10-23","kind":"exercise","acquired":true,"shares":6373,"price":6,"value":38238.0,"ownership":{"direct":true},"balance_after":294162,"source":{"system":"sec-edgar","filing":"0001213900-17-010951","document":"f4102317sank_oramedpharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017010951/f4102317sank_oramedpharm.xml","form_type":"4"}},{"id":4180739,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-25T20:35:37.000Z","date":"2017-10-23","kind":"exercise","acquired":true,"shares":5631,"price":6,"value":33786.0,"ownership":{"direct":true},"balance_after":287789,"source":{"system":"sec-edgar","filing":"0001213900-17-010951","document":"f4102317sank_oramedpharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017010951/f4102317sank_oramedpharm.xml","form_type":"4"}},{"id":4230965,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2017-08-17T20:22:43.000Z","date":"2017-08-15","kind":"exercise","acquired":false,"shares":11262,"price":1.1796,"value":13284.6552,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The number of shares underlying such warrant and the applicable exercise price reflect a one-for-twelve reverse stock split effected by the issuer on January 22, 2013."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares and warrants were purchased as \"units\" at a price per unit of $4.44 in connection with the Issuer's 2012 private placement.  The consideration was allocated to the shares and warrants based on relative fair value. The value allocated to the warrants was estimated by using the Black Scholes option-pricing model."}],"balance_after":0,"derivative":{"exercise_price":6,"exercise_date":"2012-08-15","expiration_date":"2017-08-15","underlying":"Common Stock","underlying_shares":11262},"source":{"system":"sec-edgar","filing":"0001213900-17-008889","document":"f4081517sank_oramedpharma.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017008889/f4081517sank_oramedpharma.xml","form_type":"4"}},{"id":4230964,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-17T20:22:43.000Z","date":"2017-08-15","kind":"exercise","acquired":true,"shares":11262,"price":6,"value":67572.0,"ownership":{"direct":true},"balance_after":282158,"source":{"system":"sec-edgar","filing":"0001213900-17-008889","document":"f4081517sank_oramedpharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017008889/f4081517sank_oramedpharma.xml","form_type":"4"}},{"id":4264862,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":78757,"kind":"person","name":"Sank Leonard","position":1,"cik":"0001416089","reported_name":"Sank Leonard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-05T19:46:15.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":16773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in 3 equal installments of 5,591 on each of December 31, 2017, December 31, 2018 and December 31, 2019."}],"balance_after":16773,"derivative":{"exercise_price":7.77,"expiration_date":"2027-06-30","underlying":"Common Stock","underlying_shares":16773},"source":{"system":"sec-edgar","filing":"0001213900-17-007164","document":"f4063017sank_oramed.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017007164/f4063017sank_oramed.xml","form_type":"4"}}]}